Name: Mara Medeiros Domingo
Medical Degree (MD) obtained at the School of Medicine, National Autonomous University of Mexico; 1984-1989
Research Fellow in Pharmacology: Department of Pharmacology, National Autonomous University of Mexico. Conducted research in Chronopharmacology; 1989.
Residency in Pediatrics, Hospital Infantil de Mexico Federico Gómez, National Autonomous University of Mexico; 1990-1992.
Residency in Pediatric Nephrology, Hospital Infantil de Mexico Federico Gómez, 1993-1995
Certified by the Mexican Council of Nephrology; February 23, 1996. Recertified 2003, 2005.
Graduate of Clinical Pharmacology, School of Medicine, National Autonomous University of Mexico (UNAM); March-December 1996.
PhD in Biomedical Sciences, National Autonomous University of Mexico; 1997-2000.
Post-Doctoral Fellowship. Department of Nephrology/Transplantation Medicine. Weill Medical College of Cornell University. September 2000- October 2003
Visting Professor UBC Children’s Hospital Vancouver 2013-2015
email: medeiro.mara@gmail.com
Chief of “ Unidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo”, Hospital Infantil de México Federico Gómez
Professor of Pharmacology, UNAM
Professor Epidemiology postgraduate program, UNAM
National Researcher Level III, Sistema Nacional de Investigadores, México
President Sociedad Mexicana de Trasplantes
Expresident Instituto Mexicano Investigaciones Nefrológicas
Member of ALANEPE Council
Research lines
Renal transplantation: Rejection biomarkers, pharmacokinetics of immunosuppresants, post-transplant infectious diseases, treatment and prevention of post-transplant metabolic síndrome, treatment of chronic allograft nephropaty.
Biomarkers of kidney disease progression.
Nutrition and dialysis adequacy in children.
Hypertension and AMBP in children.
Bone mineral metabolism in patients with kidney diseases
Bioethics in nephrology.
Renal Tubular acidosis
Genetics in nephrotoxicity
Early detection of kidney diseases in children.
150 peer-reviewed publications
Presumed donor in the opinion of mexican health personnel
Carlos Martínez1, Josefina Alberu2, Rodrigo Lopez-Falcony3, Mara Medeiros1.
1Nephrology and Bone Mineral Metabolism Research and Diagnosis Unit, Children's Hospital of Mexico Federico Gómez, Cuauhtemoc, , Mexico; 2School of Medicine, Tecnologico de Monterrey, Tlalpan, , Mexico; 3State Transplant Center, Secretaria de salud, Guanajuato, , Mexico
Introduction: Presumed consent (Opt out) is an organ donation policy for transplant purposes that assumes that everyone becomes a donor at death unless there is evidence that the individual decided otherwise during life. In Mexico there is a tacit consent (Opt in) that requires obtaining the consent of the family to be able to procure organs from someone who has died, currently the idea of being able to implement the policy of donor by presumed consent is being explored through a reform of the General Law of Health.
Objectives: To know the general position of health personnel related to the transplants area, who may or not be members of the Mexican Society of Transplants about the legal figure of the presumed donor and if its implementation in the Mexican Health System would be feasible.
Materials and methods: Health personnel related to the transplant area were invited to participate in a questionnaire. The questions included: Age, occupation, place of work, if they were aware of the law reform proposal, if they considered that said reform would solve the problems of transplants in Mexico, and finally, some measures or strategies that could be taken with a Likert scale. The answers were disaggregated according to the professional profile for analysis.
Results: There were 346 responses, 149 from medical staff and 197 from nursing staff. 69% of the nursing staff consider that presumed consent would improve the outlook for transplants in the country, otherwise 66% of doctors who think it wouldn’t be an improval. Both groups agree that more specific economic resources should be allocated to transplants, as well as guaranteeing patients access to universal and free coverage for surgery and immunosuppression.
Conclusions: It is important to propose strategies that allow equitable access to health to increase donation rates and improve transplant outcomes.
